Importer of Controlled Substances Application: AndersonBrecon, Inc., 21813-21814 [2019-10007]
Download as PDF
<![CDATA[
21813
Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices
Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
DEPARTMENT OF JUSTICE
Controlled substance
Drug Enforcement Administration
[FR Doc. 2019–10028 Filed 5–14–19; 8:45 am]
[Docket No. DEA–392]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Importer of Controlled Substances
Application: S & B Pharma, Inc
Drug Enforcement Administration
ACTION:
[Docket No. DEA–392]
DATES:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before June 14, 2019. Such persons
may also file a written request for a
hearing on the application on or before
June 14, 2019.
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
The registrant listed below
has applied for and been granted a
registration by the Drug Enforcement
Administration (DEA) as a bulk
manufacturer of various classes of
schedule I controlled substances.
SUMMARY:
The
company listed below has applied to be
registered as a bulk manufacturer of
various basic classes of controlled
substances. Information on the
previously published notice is listed
below. No comments or objections were
submitted for the notice.
Company
FR docket
84 FR 2579
Published
February 7,
2019
jbell on DSK3GLQ082PROD with NOTICES
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
the registration of this registrant to
manufacture the applicable basic class
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed company.
Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–10025 Filed 5–14–19; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
22:43 May 14, 2019
Jkt 247001
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
SUPPLEMENTARY INFORMATION:
Kinetochem, LLC ..............
Notice of application.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
December 24, 2018, S & B Pharma, Inc.,
dba: Norac Pharma, 405 South Motor
Avenue, Azusa, California 91702–3232
applied to be registered as an importer
of the following basic class of controlled
substances:
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
4-Anilino-N-phenethyl-4piperidine (ANPP).
Tapentadol .....................
Drug code
Schedule
8333
II
9780
II
The company plans to import the
listed controlled substances in bulk for
the manufacture of controlled
substances for distribution to its
customers.
Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–10008 Filed 5–14–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: AndersonBrecon, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration on or before June
14, 2019. Such persons may also file a
written request for a hearing on the
application on or before June 14, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
DATES:
E:\FR\FM\15MYN1.SGM
15MYN1
21814
Federal Register / Vol. 84, No. 94 / Wednesday, May 15, 2019 / Notices
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on March
05, 2019, AndersonBrecon, Inc., 4545
Assembly Drive, Rockford, Illinois
61109–3081 applied to be registered as
an importer of the following basic class
of controlled substance:
Controlled substance
Drug
code
Schedule
Tetrahydrocannabinols .....
7370
I
The company plans to import the
listed controlled substances for clinical
trial only. Approval of permit
applications will occur only when the
registrant’s business activity is
consistent with what is authorized
under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of FDA approved or nonapproved finished dosage forms for
commercial sale.
Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–10026 Filed 5–14–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1122–0023]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Currently Approved Collection
[FR Doc. 2019–10007 Filed 5–14–19; 8:45 am]
BILLING CODE 4410–09–P
Drug Enforcement Administration
Office on Violence Against
Women, Department of Justice.
ACTION: 30-Day notice.
[Docket No. DEA–392]
SUMMARY:
AGENCY:
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Registration
ACTION:
Notice of registration.
The registrants listed below
have applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as bulk
manufacturers of schedule I and II
controlled substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as bulk manufacturers of
schedule I or schedule II controlled
substances. Information on previously
published notices is listed in the table
below. No comments or objections were
submitted for these notices.
SUMMARY:
Company
jbell on DSK3GLQ082PROD with NOTICES
the registration of the registrants to
manufacture the applicable basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the DEA has granted a
registration as a bulk manufacturer to
the above listed companies.
Johnson Matthey, Inc ........
FR docket
Published
84 FR 5477
February 21,
2019.
February 21,
2019.
February 21,
2019.
Stepan Company ..............
84 FR 5499
Research Triangle Institute
84 FR 5501
The DEA has considered the factors in
21 U.S.C. 823(a) and determined that
VerDate Sep<11>2014
22:43 May 14, 2019
Jkt 247001
The Department of Justice,
Office on Violence Against Women
(OVW) will be submitting the following
information collection request to the
Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 30 days until June
14, 2019.
FOR FURTHER INFORMATION CONTACT:
Written comments and/or suggestion
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to Cathy Poston,
Office on Violence Against Women, at
202–514–5430 or Catherine.poston@
usdoj.gov. Written comments and/or
suggestions can also be sent to the
Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention Department of Justice
Desk Officer, Washington, DC 20530 or
sent to OIRA_submissions@
omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection: SemiAnnual Progress Report for Grantees
from the Sexual Assault Services
Program—Grants to Culturally Specific
Programs (SASP-Culturally Specific
Program).
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: 1122–0023.
U.S. Department of Justice, Office on
Violence Against Women.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: The affected public includes
the approximately 11 grantees of the
SASP Culturally Specific Program. This
program supports projects that create,
maintain and expand sustainable sexual
assault services provided by culturally
specific organizations, which are
uniquely situated to respond to the
needs of sexual assault victims within
culturally specific populations.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that it will
take the approximately 11 respondents
(SASP-Culturally Specific Program
grantees) approximately one hour to
complete a semi-annual progress report.
The semi-annual progress report is
divided into sections that pertain to the
different types of activities in which
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 84, Number 94 (Wednesday, May 15, 2019)]
[Notices]
[Pages 21813-21814]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10007]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: AndersonBrecon,
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before June 14, 2019. Such
persons may also file a written request for a hearing on the
application on or before June 14, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been
[[Page 21814]]
redelegated to the Assistant Administrator of the DEA Diversion Control
Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR
part 0, appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on March
05, 2019, AndersonBrecon, Inc., 4545 Assembly Drive, Rockford, Illinois
61109-3081 applied to be registered as an importer of the following
basic class of controlled substance:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols.................. 7370 I
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
clinical trial only. Approval of permit applications will occur only
when the registrant's business activity is consistent with what is
authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the import of FDA approved or non-
approved finished dosage forms for commercial sale.
Dated: April 27, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-10007 Filed 5-14-19; 8:45 am]
BILLING CODE 4410-09-P
